H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report)’s stock price fell 49.5% during mid-day trading on Monday . The stock traded as low as $2.02 and last traded at $2.02. 400 shares traded hands during mid-day trading, an increase of 288% from the average session volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Price Performance
The company has a 50-day moving average price of $2.02 and a 200-day moving average price of $2.02.
H-CYTE Company Profile
H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than H-CYTE
- Airline Stocks – Top Airline Stocks to Buy Now
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Earnings Per Share Calculator: How to Calculate EPS
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
